Our Services
Clinical Trial Management Services
Central Laboratory Services
Clinical Pharmacology
Scintigraphy
Pharmacovigilance
Regulatory Affairs
Clinical & Medical Writing
Clinical Trial Management Services
Phase I
Phase II
Phase III
Site Management & Monitoring
IMP Management
Biometric Services
A large pharmaceutical Sponsor needed to demonstrate that its novel triple combination pMDI formulation could effectively deliver drugs to the lungs of patients with moderate and severe/ very severe COPD as defined by the European Respiratory Society.
